We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+13.82%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$13B
AUM Growth
+$1.56B
(+14%)
Cap. Flow
+$261M
Cap. Flow
% of AUM
2.02%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
1,179
New
174
Increased
377
Reduced
434
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$128M |
| 2 |
Electronic Arts
EA
|
+$79.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$75M |
| 4 |
Target
TGT
|
+$74.4M |
| 5 |
Amazon
AMZN
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Starbucks
SBUX
|
+$121M |
| 3 |
Micron Technology
MU
|
+$83M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$58.2M |
| 5 |
Kimberly-Clark
KMB
|
+$53.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.12% |
| 2 | Healthcare | 14.04% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Financials | 12.63% |
| 5 | Industrials | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Kiniksa Pharmaceuticals
KNSA
$6.23B
| $935K | 0.01% |
50,513
+11,119
| +28% | +$227K |
|
|
CNR
752
Core Natural Resources Inc
CNR
$3.93B
| $932K | 0.01% |
95,914
-38,473
| -29% | -$376K |
|
753
Chemed
CHE
$7.16B
| $929K | 0.01% |
2,020
+650
| +47% | +$319K |
|
754
Meridian
MRBK
$242M
| $925K | 0.01% |
71,124
+43,946
| +162% | +$517K |
|
755
Heritage Financial
HFWA
$1.22B
| $923K | 0.01% |
32,677
-199
| -0.6% | -$5.21K |
|
|
KE
756
Kimball Electronics
KE
$564M
| $909K | 0.01% |
35,235
+15,629
| +80% | +$356K |
|
757
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
| $908K | 0.01% |
1,908
| – | – |
|
758
Ducommun
DCO
$2.56B
| $903K | 0.01% |
+15,052
| New | +$841K |
|
759
Old Republic International
ORI
$10.9B
| $897K | 0.01% |
+41,091
| New | +$823K |
|
|
CLDR
760
DELISTED
Cloudera, Inc.
CLDR
| $894K | 0.01% |
+73,495
| New | +$1.1M |
|
|
CSTR
761
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $890K | 0.01% |
51,588
+375
| +0.7% | +$6.02K |
|
762
Ovid Therapeutics
OVID
$427M
| $886K | 0.01% |
220,357
+182,514
| +482% | +$606K |
|
|
AUD
763
DELISTED
Audacy, Inc.
AUD
| $883K | 0.01% |
168,134
-528,135
| -76% | -$2.57M |
|
764
First Bancorp
FBNC
$2.61B
| $882K | 0.01% |
20,271
-38,400
| -65% | -$1.53M |
|
765
Solid Biosciences
SLDB
$792M
| $882K | 0.01% |
10,631
-10,198
| -49% | -$1.13M |
|
|
VBTX
766
DELISTED
Veritex Holdings
VBTX
| $877K | 0.01% |
+26,814
| New | +$791K |
|
767
Blackbaud
BLKB
$1.94B
| $876K | 0.01% |
+12,330
| New | +$851K |
|
768
Geospace Technologies
GEOS
$84M
| $875K | 0.01% |
95,968
+39,222
| +69% | +$377K |
|
|
CSLT
769
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $875K | 0.01% |
579,752
-6,722
| -1% | -$11.7K |
|
|
BLD
770
DELISTED
TopBuild
BLD
| $873K | 0.01% |
4,170
| – | – |
|
|
PPLI
771
People Inc
PPLI
$3.12B
| $873K | 0.01% |
+7,393
| New | +$918K |
|
772
SPX Corp
SPXC
$9.39B
| $866K | 0.01% |
14,867
-78,843
| -84% | -$4.49M |
|
773
Quad
QUAD
$479M
| $860K | 0.01% |
243,518
+88,735
| +57% | +$423K |
|
774
Bankunited
BKU
$3.33B
| $858K | 0.01% |
19,521
-21,677
| -53% | -$890K |
|
|
MNTV
775
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $856K | 0.01% |
+46,720
| New | +$1.05M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2021 Portfolio in Review
As of Q1 2021, Jacobs Levy Equity Management held 1,179 positions worth $13B, up 14% from $11.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management's Q1 2021 filing shows 174 new, 377 increased, 434 reduced and 179 closed positions. Its largest new stake was Target: 397,775 shares worth $78.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q1 2021 buy was Target: 397,775 shares worth $78.8M.
- Jacobs Levy Equity Management added most to Costco in Q1 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- Jacobs Levy Equity Management fully exited Starbucks in Q1 2021, selling an estimated $121M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $13B portfolio in Q1 2021.
- Jacobs Levy Equity Management opened 174 new positions and closed 179 in Q1 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $13B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2021, filed 17 May 2021.